2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
Strategy Gross of Fees | -10.89% | 19.05% | -10.46% | 22.29% | -8.80% | 10.00% | 32.12% | 2.61% |
Strategy Net of Fees | -11.53% | 18.16% | -11.22% | 21.37% | -9.44% | 9.35% | 31.71% | 2.61% |
S&P 600 Low Volatility | -11.50% | 29.84% | -17.21% | 22.76% | -5.13% | 8.92% | 31.72% | 3.00% |
Excess Return | 0.60% | -10.79% | 6.75% | -0.47% | -3.67% | 1.08% | 0.40% | -0.39% |
Strategy Gross of Fees | -10.89% | 19.05% | -10.46% | 22.29% | -8.80% | 10.00% | 32.12% | 2.61% |
Strategy Net of Fees | -11.53% | 18.16% | -11.22% | 21.37% | -9.44% | 9.35% | 31.71% | 2.61% |
Russell 2000 | -20.46% | 14.78% | 19.93% | 25.49% | -11.03% | 14.63% | 21.28% | -4.41% |
Excess Returns | 9.57% | 4.27% | -30.39% | -3.19% | 2.23% | -4.63% | 10.84% | 7.03% |
Past performance does not guarantee future results.
Characteristics | Strategy | S&P 600 Low Volatility | Russell 2000 |
Strategy Assets ($ Million) | 36.78 | - | - |
Number of Holdings | 104 | 119 | 2000 |
Beta* | 0.55 | 0.76 | 1.00 |
Standard Deviation* (%) | 0.14 | 0.19 | 0.22 |
Market Cap. ($ Billion) | 2.92 | 1.39 | 2.59 |
Price to Trailing Earnings | 18.19 | 18.53 | 17.93 |
Price to Cash Flow | 12.76 | 11.77 | 11.50 |
Price to Book | 2.54 | 1.53 | 2.36 |
Enterprise Value to Sales | 2.14 | 2.95 | 2.65 |
Debt as % of Assets | 19.99 | 19.58 | 26.15 |
Return on Equity (%) | 15.49 | 9.71 | 9.51 |
Top 10 Holdings | Ticker | Weight |
AMPHASTAR PHARMACEUTICALS IN | AMPH | 2.73% |
UFP TECHNOLOGIES INC | UFPT | 2.43% |
EXLSERVICE HOLDINGS INC | EXLS | 2.38% |
PRESTIGE CONSUMER HEALTHCARE | PBH | 2.36% |
COPA HOLDINGS SA-CLASS A | CPA | 2.34% |
WERNER ENTERPRISES INC | WERN | 2.22% |
SILGAN HOLDINGS INC | SLGN | 2.20% |
REXFORD INDUSTRIAL REALTY IN | REXR | 2.07% |
US DOLLAR | USD | 2.03% |
BALCHEM CORP | BCPC | 1.99% |
Risk Statistics since February 01, 2014 | Strategy | S&P 600 Low Volatility | Russell 2000 |
Annualized Return | 7.51% | 7.89% | 7.02% |
Annualized Standard Deviation | 15.45% | 17.35% | 19.79% |
Return/Risk | 0.49 | 0.45 | 0.35 |
Tracking Error | 9.32% | 9.12% | - |
R-Squared | 79.01% | 60.83% | - |
Alpha | 2.40% | 0.32% | - |
Beta | 0.69 | 0.78 | - |
Performance numbers for the most recent period are preliminary and subject to change. Returns for periods of less than one year are not annualized. Past performance is not a reliable indicator of future performance and should not be relied upon to make investment decisions. Investing involves risks including the possible loss of principal and fluctuation in value. Performance includes the reinvestment of dividends and other earnings.
Performance figures are presented net of fees or both gross and net. In some instances, fees deducted are actual, in other instances, fees deducted are the highest charged in the composite/portfolio. Actual fees may vary depending on, among other things, the applicable fees schedule and portfolio size. SGI fees are available upon request and may also be found in Part 2A of its Form ADV.
Composite returns are calculated from account-level returns based on account membership in the composite during the daily holding period and applying a beginning asset-weighted methodology to each account. Performance includes the reinvestment of dividends and other earning. Investing involves risks including the possible loss of principal and fluctuation in value. The volatility of the indices may be materially different from the individual performance attained by a specific investor. In addition, SGI’s holdings may differ significantly from the securities that comprise the indices. The indices have not been selected to represent an appropriate benchmark to compare an investor’s performance, but rather are disclosed to allow for comparison of the investor’s performance to that of certain well-known and widely recognized indices. You cannot invest directly in an index.
For a GIPS-compliant composite presentation, see this Fact Sheet: U.S. Small Cap Equity Strategy 2023 Q3